| 英文品名 |
dalotuzumab |
| 名称来源 |
p-INNList-102,2009;r-INNList-64,2010; |
| 化学表述 |
immunoglobulin G1-kappa, anti-[Homo sapiens IGF1R (insulin-like growth factor 1 receptor, IGF1-R, IGF-1R, CD221], humanized monoclonal antibody;
gamma1 heavy chain (1-447) [humanized VH (Homo sapiens IGHV4-61*08 (79.80%) -(IGHD)-IGHJ4*01) [9.7.10] (1-117) -Homo sapiens IGHG1*03 (118-447)], (220-219')-disulfide with kappa light chain (1'-219') [humanized V-KAPPA (Homo sapiens IGKV2-29*02 (78.00%) -IGKJ1*01) [11.3.9] (1'-112') -Homo sapiens IGKC*01 (113'-219')]; (226-226":229-229")-bisdisulfide dimer |
| CA登记号 |
1005389-60-5 |
| 分 子 式 |
C6528H10086N1730O2018S40 |
| 结 构 式 |
|
| 品种类别 |
antineoplastic; |
|
